These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2202336)

  • 1. Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris.
    Kemény L; Ruzicka T; Braun-Falco O
    Skin Pharmacol; 1990; 3(1):1-20. PubMed ID: 2202336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tazarotene increases the antipsoriatic effect of dithranol in chronic psoriasis].
    Sander P; Happe M; Stücker M; Hermes N; Hoffmann K; Altmeyer P
    Hautarzt; 1999 Oct; 50(10):723-7. PubMed ID: 10550358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of psoriasis with anthrones-chemical principles, biochemical aspects, and approaches to the design of novel derivatives.
    Wiegrebe W; Müller K
    Skin Pharmacol; 1995; 8(1-2):1-24. PubMed ID: 7786521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). II. Clinical comparison of dithranol and butantrone sticks with special reference to side effects.
    Brandt H
    Acta Derm Venereol; 1987; 67(1):55-61. PubMed ID: 2436415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-contact therapy for psoriasis with 3.9% butantrone (10-butyryl dithranol).
    Remitz A
    Acta Derm Venereol; 1989; 69(4):351-4. PubMed ID: 2568062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid.
    Swinkels OQ; Prins M; Kucharekova M; de Boo T; Gerritsen MJ; van der Valk PG; van de Kerkhof PC
    Br J Dermatol; 2002 Apr; 146(4):621-6. PubMed ID: 11966693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical assessment of the response of the psoriatic lesion to single and repeated applications of high-dose dithranol cream.
    Swinkels OQ; Prins M; Gerritsen MJ; van Vlijmen-Willems IM; van der Valk PG; van de Kerkhof PC
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):393-400. PubMed ID: 12476013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsoriatic and proinflammatory action of anthralin. Implications for the role of oxygen radicals.
    Müller K
    Biochem Pharmacol; 1997 May; 53(9):1215-21. PubMed ID: 9214681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dithranol on neutrophil superoxide generation in patients with psoriasis.
    Kavanagh GM; Burton JL; Donnell VO
    Br J Dermatol; 1996 Feb; 134(2):234-7. PubMed ID: 8746335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free radicals and the treatment of psoriasis with special reference to dithranol.
    Mustakallio KK; Martinmaa J; Vilvala R; Halmekoski J
    Med Biol; 1984; 62(2):155-8. PubMed ID: 6471937
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antipsoriatic effect of dithranol (anthralin). 1].
    Raab W
    Hautarzt; 1975 Sep; 26(9):452-5. PubMed ID: 1184389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes.
    Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC
    J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of a topical corticosteroid on short-contact high-dose dithranol therapy.
    Swinkels OQ; Prins M; Tosserams EF; Gerritsen MJ; Van Der Valk PG; Van De Kerkhof PC
    Br J Dermatol; 2001 Jul; 145(1):63-9. PubMed ID: 11453908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urea in combination with dithranol in treating psoriasis vulgaris].
    Przybilla B; Kaudewitz P; Bieber K
    Hautarzt; 1989; 40 Suppl 9():54-7. PubMed ID: 2681078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response and side-effects in the treatment of psoriasis with UV-B and -A novel dithranol formulation.
    Christensen OB; Holst R; Hradil E; Brolund L
    Acta Derm Venereol Suppl (Stockh); 1989; 146():96-100; discussion 101. PubMed ID: 2609898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of psoriasis with dithranol cream compared with dithranol paste.
    Young E
    Dermatologica; 1986; 173(6):285-7. PubMed ID: 3817239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dithranol in an emulsifying oil base (bio-wash-oil) for the treatment of psoriasis of the scalp.
    Wulff-Woesten A; Ohlendorf D; Henz BM; Haas N
    Skin Pharmacol Physiol; 2004; 17(2):91-7. PubMed ID: 14976386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of epidermal growth factor receptors by dithranol.
    Kemény L; Michel G; Arenberger P; Ruzicka T
    Acta Derm Venereol; 1993 Feb; 73(1):37-40. PubMed ID: 8095749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dithranol and butantrone in short contact therapy of psoriasis.
    Göransson A
    Acta Derm Venereol; 1987; 67(2):149-53. PubMed ID: 2438880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.